CYCLE FOR SURVIVAL 2018
Every dollar represents hope, strength, and a lasting impact!
January 10, 2018
December 19, 2017
With the holiday season in full swing, it’s hard not to reflect on this past year and realize how thankful Veristat is to play such an instrumental role in the world of clinical research.
December 14, 2017
Veristat aspires to make a difference, every day!
As the weather gets colder and we find ourselves in the holiday season, the employees of Veristat decided to make a difference by helping others in their local communities.
November 17, 2017
A Recap of the New York Medidata NEXT Event: Where Science Meets Technology Meets the Future
Kathleen Boruchowski, Associate Director of Data Management, attended the Medidata NEXTconference in New York City on November 8-10. The conference, which has many global locations throughout the year, offered Medidata’s customers a front row seat to learn how data, insights, and technology are transforming the clinical trials industry and ultimately accelerating the hope for patients desperately seeking new treatment options.
November 8, 2017
Veristat Hosts Its 2017 Annual International Company Meeting
Last week, Veristat gathered nearly 200 team members from multiple countries for our annual International Company Meeting. What better a place to host our team meeting than Gillette Stadium, home to the five-time Superbowl championship winning New England Patriots.
October 3, 2017
In pharmaceutical clinical trials, considering competing risk analyses is highly important. Competing risks are events that may occur and prevent the evaluation of a specific primary endpoint, in turn biasing risk estimations or drug efficacy.
August 15, 2017
To Improve Real-Time Visibility of Clinical Trial Documentation and Inspection-Readiness
Veristat has completed the validation and configuration of Master Control’s eTMF system, which is now implemented and available for Veristat managed clinical trials.
August 3, 2017
Last week, Veristat attended the Massachusetts Biotechnology Council (MassBio) forum titled “Evolution of an Academic Discovery: First Person Account of the Development of Velcade®”.
Veristat Participates in Cycle for Survival 2017 and Raises over $25,000 to Fund Rare Cancer Research
February 23, 2017
On Saturday, February 4, Team Veristat joined the battle against rare cancers at the 2017 Cycle for Survival event! Team Veristat had 14 riders at the Boston, MA event, including 2 colleagues from our UK office. Our team surpassed our goal of raising over $25,000 to fund rare cancer research!